SB 1330 proposes to create a new chapter (Chapter 566) in the Texas Insurance Code to regulate billing practices related to durable medical equipment, orthotic devices, and prosthetic supplies provided to Medicare enrollees by nonparticipating suppliers. These suppliers are defined as individuals or entities that provide Medicare-covered medical equipment or supplies but are not enrolled in Medicare as participating providers. The bill aims to align state-level oversight with federal Medicare billing standards, targeting out-of-network suppliers who may charge excessive rates to vulnerable beneficiaries.
The legislation places a cap on what nonparticipating suppliers can charge Medicare enrollees, limiting charges to no more than 115 percent of the Medicare-approved amount for covered items. It also mandates that these suppliers provide notice to enrollees regarding their billing status and the amount approved by Medicare for the specific equipment or supply. This transparency requirement seeks to empower consumers with clearer cost expectations before services are rendered.
In addition to regulatory measures, the bill includes criminal penalties for suppliers who willfully and repeatedly violate the established billing limitations. This provision introduces a criminal offense to discourage systemic overcharging and enforce compliance through state law. The bill represents an effort to protect Medicare enrollees—typically seniors or individuals with disabilities—from surprise billing or financial exploitation, especially when receiving essential medical equipment from providers not contracted with Medicare.
Overall, SB 1330 expands state-level regulation in the healthcare marketplace where federal oversight may fall short while aiming to balance consumer protection with supplier accountability.
The Committee Substitute for SB 1330 introduces several key changes that mark a shift in the bill’s regulatory philosophy compared to the originally filed version. Most notably, the substitute eliminates provisions that previously allowed nonparticipating suppliers to exceed the 115% Medicare-approved billing cap if specific notice and consent conditions were met. In the original bill, suppliers could charge more than this cap if the Medicare enrollee agreed in writing and paid the additional amount in advance. By removing this flexibility, the substitute imposes a firm price ceiling, aiming to provide more uniform protection to enrollees from unexpected or excessive out-of-network costs.
Another major change is the simplification of the enforcement mechanism. While both versions criminalize intentional violations, the originally filed bill also invoked the Texas Deceptive Trade Practices Act and specified jurisdictions for prosecution. The Committee Substitute streamlines this by focusing on repeated and willful violations as the basis for criminal liability, perhaps to clarify enforcement pathways and avoid entanglement with broader consumer protection statutes.
Additionally, the original bill included a new section in Chapter 1652 of the Insurance Code clarifying that Medicare supplement plan issuers were not obligated to reimburse charges above the 115% threshold, though they could negotiate reimbursement terms. This provision is omitted in the committee substitute, suggesting a desire to simplify the bill's scope or avoid potential conflicts with federal or contractual insurance standards.
Structurally, the substitute reorganizes the bill into clearly labeled subchapters for general provisions, billing regulation, and enforcement. This makes the bill more navigable and logically segmented, reflecting standard drafting practices for legislation affecting insurance and health care regulation. The result is a tighter, more consumer-focused bill with firmer controls and fewer exceptions.
